M&RP Recent Publications
Below are links to articles recently published regarding measles and rubella (listed first) as well as for articles of interest for other immunization (listed further below.)
Measles and Rubella Citations, Third Quarter of 2024
-
Possible Paths to Measles Eradication: Conceptual Frameworks, Strategies, and Tactics.
Winter AK, Moss WJ.
Vaccines (Basel). 2024 Jul 22;12(7):814.
doi: 10.3390/vaccines12070814.PMID: 39066451
-
Optimal Timing Regularly Outperforms Higher Coverage in Preventative Measles Supplementary Immunization Campaigns.
Rosenfeld KA, Frey K, McCarthy KA.
Vaccines (Basel). 2024 Jul 22;12(7):820.
doi: 10.3390/vaccines12070820.PMID: 39066459
-
Measles: What goes around, comes around.
Moss WJ, Griffin DE.
J Infect Dis. 2024 Aug 8:jiae397.
doi: 10.1093/infdis/jiae397. Online ahead of print.PMID: 39115343
No abstract available.
-
Tracking Measles and Rubella Elimination Progress-World Health Organization African Region, 2022-2023.
Masresha BG, Wiysonge CS, Katsande R, O’Connor PM, Lebo E, Perry RT.
Vaccines (Basel). 2024 Aug 22;12(8):949.
doi: 10.3390/vaccines12080949.PMID: 39204072
-
The Problem with Delaying Measles Elimination.
Crowcroft NS, Minta AA, Bolotin S, Cernuschi T, Ariyarajah A, Antoni S, Mulders MN, Bose AS, O’Connor PM.
Vaccines (Basel). 2024 Jul 22;12(7):813.
doi: 10.3390/vaccines12070813.PMID: 39066457
-
What's going on with measles?
Moss WJ, Griffin DE.
J Virol. 2024 Aug 20;98(8):e0075824.
doi: 10.1128/jvi.00758-24. Epub 2024 Jul 23.PMID: 39041786
-
Exploring Important Attributes, the Potential Use Cases and Feasibility of Introduction of Measles and Rubella Microarray Patches (MR-MAPs): Insights from Nine Countries.
Hasso-Agopsowicz M, Spasenoska D, Jansen MPM, Masresha BG, Pastor D, Gebrekidan AH, Silalahi O, Woolford J, Kisakye A, Kahn AL, Giersing B.
Vaccines (Basel). 2024 Sep 23;12(9):1084.
doi: 10.3390/vaccines12091084.PMID: 39340114
-
Estimates of Potential Demand for Measles and Rubella Microarray Patches.
Kayembe LK, Fischer LS, Adhikari BB, Knapp JK, Khan EB, Greening BR, Papania M, Meltzer MI.
Vaccines (Basel). 2024 Sep 23;12(9):1083.
doi: 10.3390/vaccines12091083.PMID: 39340113
-
Progress with the Second Dose Measles Vaccine Introduction and Coverage in the WHO African Region.
Masresha BG, Shibeshi ME, Grant GB, Hatcher C, Wiysonge CS.
Vaccines (Basel). 2024 Sep 18;12(9):1069.
doi: 10.3390/vaccines12091069.PMID: 39340099
-
On the Path to Measles and Rubella Elimination Following Rubella-Containing Vaccine Introduction, 2000-2023, Namibia.
Masresha BG, Shibeshi ME, de Wee R, Shapumba N, Sayi T, Reef SE, Goodson JL.
Vaccines (Basel). 2024 Aug 23;12(9):957.
doi: 10.3390/vaccines12090957.PMID: 39339990
-
Measles and Rubella Elimination in the Western Pacific Region in 2013-2022: Lessons Learned from Progress and Achievements Made during Regional and Global Measles Resurgences.
Takashima Y, Aslam SK, Evans R, Mariano KM, Lee CW, Wang X, Grabovac V, Durrheim DN.
Vaccines (Basel). 2024 Jul 22;12(7):817.
doi: 10.3390/vaccines12070817.PMID: 39066454
-
Epidemiology of measles outbreaks, incidence and associated risk factors in Ethiopia from 2000 to 2023: a systematic review and meta-analysis.
Eshetu D, Tosisa W, Regassa BT, Hundie GB, Mulu A.
BMC Infect Dis. 2024 Sep 3;24(1):914.
doi: 10.1186/s12879-024-09828-6.PMID: 39227789
-
Factors Associated with Uptake of Routine Measles-Containing Vaccine Doses among Young Children, Oromia Regional State, Ethiopia, 2021.
Woyessa AB, Shah MP, Azmeraye BM, Pan J, Lisanwork L, Yimer G, Wang SH, Nuorti JP, Artama M, Matanock AM, An Q, Samuel P, Tolera B, Kenate B, Bekele A, Deti T, Wako G, Shiferaw A, Tefera YL, Kokebie MA, Anbessie TB, Wubie HT, Wallace A, Sugerman CE.
Vaccines (Basel). 2024 Jul 11;12(7):762.
doi: 10.3390/vaccines12070762.PMID: 39066400
-
Measles Outbreak Investigation in Aneded District, Northwest Ethiopia: A Case-Control Study.
Tariku MK, Belete AH, Worede DT, Tegegne BA, Bante SA, Misikir SW.
J Epidemiol Glob Health. 2024 Sep;14(3):1231-1241.
doi: 10.1007/s44197-024-00279-5. Epub 2024 Aug 1.PMID: 39088155
-
Measles second dose vaccine uptake and associated factors among under-five children in Jigjiga City, Somali Region, Eastern Ethiopia: a community-based cross-sectional study.
Ibrahim HA, Wariyo A, Asefa EM, Cheru A, Abebe Lonsako A, Dirirsa G.
Front Public Health. 2024 Jul 30;12:1395802.
doi: 10.3389/fpubh.2024.1395802. eCollection 2024.PMID: 39139669
-
Estimating immunization coverage at the district level: A case study of measles and diphtheria-pertussis-tetanus-Hib-HepB vaccines in Ethiopia.
Tesfaye L, Forzy T, Getnet F, Misganaw A, Woldekidan MA, Wolde AA, Warkaye S, Gelaw SK, Memirie ST, Berheto TM, Worku A, Sato R, Hendrix N, Tadesse MZ, Tefera YL, Hailu M, Verguet S.
PLOS Glob Public Health. 2024 Jul 25;4(7):e0003404.
doi: 10.1371/journal.pgph.0003404. eCollection 2024.PMID: 39052537
-
Qualitative Insights on Barriers to Receiving a Second Dose of Measles-Containing Vaccine (MCV2), Oromia Region of Ethiopia.
Solomon K, Aksnes BN, Woyessa AB, Geri C, Matanock AM, Shah MP, Samuel P, Tolera B, Kenate B, Bekele A, Deti T, Wako G, Shiferaw A, Tefera YL, Kokebie MA, Anbessie TB, Wubie HT, Wallace A, Sugerman CE, Kaba M.
Vaccines (Basel). 2024 Jun 22;12(7):702.
doi: 10.3390/vaccines12070702.PMID: 39066340
-
Long-term waning of vaccine-induced immunity to measles in England: a mathematical modelling study.
Robert A, Suffel AM, Kucharski AJ.
Lancet Public Health. 2024 Sep 19:S2468-2667(24)00181-6.
doi: 10.1016/S2468-2667(24)00181-6. Online ahead of print.PMID: 39342948
-
Factors influencing the first dose of measles vaccination uptake in 42 low- and middle-income countries.
Mahazabin M, Swarna SN, Naime J, Rahman A, Islam MA.
Public Health. 2024 Sep 27;237:85-93.
doi: 10.1016/j.puhe.2024.09.017. Online ahead of print.PMID: 39341152
-
Case Study: Contribution of Extended Sequencing and Phylogeographic Analysis in the Investigation of Measles Outbreaks in Tunisia in 2019.
Chouikha A, Arbi M, Souiai O, Touzi H, Meddeb Z, Ben Farhat E, Yahyaoui M, Ben Said A, Hamouda C, Triki H.
Vaccines (Basel). 2024 Sep 23;12(9):1085.
doi: 10.3390/vaccines12091085.PMID: 39340115
-
Low Rates of Immunity among Medical Students and Residents in the Era of the Resurgence of Measles.
Ferrari C, Somma G, Caputi V, Treglia M, Pallocci M, Cenko F, Buonomo E, Carestia M, Di Giampaolo L, Olesen OF, Coppeta L.
Pathogens. 2024 Sep 11;13(9):784.
doi: 10.3390/pathogens13090784.PMID: 39338975
-
Zero-dose children and the extended immunisation cascade: Understanding the path to full immunisation with six childhood vaccines in 43 countries.
Cata-Preta BO, Silva LAN, Costa FS, Santos TM, Mengistu T, Hogan DR, Victora CG, Barros AJD.
J Glob Health. 2024 Sep 27;14:04199.
doi: 10.7189/jogh.14.04199.PMID: 39325925
-
An urgent case for measles vaccination in Gaza.
Waldman R, Steinglass R, Nieburg P.
Lancet. 2024 Sep 20:S0140-6736(24)02076-2.
doi: 10.1016/S0140-6736(24)02076-2. Online ahead of print.PMID: 39312932 No abstract available.
-
The impact of household size on measles transmission: A long-term perspective.
Bidari S, Yang W.
Epidemics. 2024 Sep 6;49:100791.
doi: 10.1016/j.epidem.2024.100791. Online ahead of print.PMID: 39276494
-
The Effects of Vaccination Status and Age on Clinical Characteristics and Severity of Measles Cases in the United States in the Post-Elimination Era, 2001-2022.
Leung J, Munir NA, Mathis AD, Filardo TD, Rota PA, Sugerman DE, Sowers SB, Mercader S, Crooke SN, Gastañaduy PA.
Clin Infect Dis. 2024 Sep 13:ciae470.
doi: 10.1093/cid/ciae470. Online ahead of print.PMID: 39271123
-
Hospital-acquired infections and unvaccinated children due to chronic diseases: an investigation of the 2017-2019 measles outbreak in the northern region of Vietnam.
Tran DM, Ong T, Cao TV, Pham QT, Do H, Phan PH, Choisy M, Pham NTH.
BMC Infect Dis. 2024 Sep 10;24(1):948.
doi: 10.1186/s12879-024-09816-w.PMID: 39256671
-
Prediction of measles cases in US counties: A machine learning approach.
Kujawski SA, Ru B, Afanador NL, Conway JH, Baumgartner R, Pawaskar M.
Vaccine. 2024 Sep 7;42(26):126289.
doi: 10.1016/j.vaccine.2024.126289. Online ahead of print.PMID: 39244426
-
Measles in the Modern Era: A Review.
Azan L, Chuecos-Escalante S, Marte AP, Bhagi N.
Pediatr Ann. 2024 Sep;53(9):e345-e350.
doi: 10.3928/19382359-20240722-01. Epub 2024 Sep 1.PMID: 39240174
-
Contradictory mortality results in early 2-dose measles vaccine trials: interactions with oral polio vaccine may explain differences.
Nielsen S, Fisker AB, Sie A, Müller O, Nebie E, Becher H, van der Klis F, Biering-Sørensen S, Byberg S, Thysen SM, da Silva I, Rodrigues A, Martins C, Whittle HC, Aaby P, Benn CS.
Int J Infect Dis. 2024 Aug 30;148:107224.
doi: 10.1016/j.ijid.2024.107224. Online ahead of print.PMID: 39218141
-
Global Status Report for the Verification of Measles and Rubella Elimination, 2022.
O’Connor P, Masresha B, Pastor D, Musa N, Hagan J, Khanal S, Lee CW, Crowcroft N.
Vaccines (Basel). 2024 Aug 22;12(8):947.
doi: 10.3390/vaccines12080947.PMID: 39204070
-
The Global Measles and Rubella Laboratory Network Supports High-Quality Surveillance.
Rota PA, Evans R, Ben Mamou MC, Rey-Benito G, Sangal L, Dosseh A, Ghoniem A, Byabamazima CR, Demanou M, Anderson R, Kim G, Bankamp B, Beard RS, Crooke SN, Ramachandran S, Penedos A, Stambos V, Nicholson S, Featherstone D, Mulders MN.
Vaccines (Basel). 2024 Aug 22;12(8):946.
doi: 10.3390/vaccines12080946.PMID: 39204069
-
Strengthening of Vaccine-Preventable Disease (VPD) Surveillance to Enhance National Health Capacity and Security: Perspective from India.
Kumar A, Murugan R, Donkatti S, Sharma D, Kaundal N, Avagyan T, Kumar P, Bahl S, Khanal S, Bura V.
Vaccines (Basel). 2024 Aug 22;12(8):941.
doi: 10.3390/vaccines12080941.PMID: 39204063
-
Using Regular High-Quality Serosurveys to Identify and Close National Immunity Gaps-Measles and Rubella Elimination in Japan.
Sunagawa T, Kobayashi Y, Takashima Y, Kamiya H, Shimada T, Nakashima K, Arai S, Taniguchi K, Tanaka-Taya K, Okabe N.
Vaccines (Basel). 2024 Aug 22;12(8):939.
doi: 10.3390/vaccines12080939.PMID: 39204061
-
Measles Population Immunity Profiles: Updated Methods and Tools.
Li X, Goodson JL, Perry RT.
Vaccines (Basel). 2024 Aug 22;12(8):937.
doi: 10.3390/vaccines12080937.PMID: 39204060
-
Mapping the Implementation Determinants of Second Dose Measles Vaccination in the World Health Organization African Region: A Rapid Review.
Adamu AA, Jalo RI, Masresha BG, Ndwandwe D, Wiysonge CS.
Vaccines (Basel). 2024 Aug 8;12(8):896.
doi: 10.3390/vaccines12080896.PMID: 39204023
-
A Serological Survey of Measles and Rubella Antibodies among Different Age Groups in Eastern China.
Yan R, He H, Deng X, Zhou Y, Tang X, Zhu Y, Liang H, Chen Y, Yang M, Du Y, Chen C, Chen J, Yang S, Ridphe Group.
Vaccines (Basel). 2024 Jul 25;12(8):842.
doi: 10.3390/vaccines12080842.PMID: 39203968
-
Building Quality Control for Molecular Assays in the Global Measles and Rubella Laboratory Network.
Bankamp B, Anderson R, Hao L, Lopareva E, Chen MH, Kim G, Beard RS, Mori Y, Otsuki N, Ryo A, Rota PA.
Vaccines (Basel). 2024 Jul 23;12(8):824.
doi: 10.3390/vaccines12080824.PMID: 39203950
-
Use of Measles and Rubella Rapid Diagnostic Tests to Improve Case Detection and Targeting of Vaccinations.
Rachlin A, Hampton LM, Rota PA, Mulders MN, Papania M, Goodson JL, Krause LK, Hanson M, Osborn J, Kelly-Cirino C, Evans B, Sinha A, Warrener L, Featherstone D, Brown D.
Vaccines (Basel). 2024 Jul 23;12(8):823.
doi: 10.3390/vaccines12080823.PMID: 39203949
-
Adjusting mobile phone data to account for children's travel and the impact on measles dynamics in Zambia.
Kostandova N, Prosperi C, Mutembo S, Nakazwe C, Namukoko H, Nachinga B, Chongwe G, Chilumba I, Kabalo EN, Makungo K, Matakala KH, Musukwa G, Hamahuwa M, Mufwambi W, Matoba J, Mutale I, Simulundu E, Ndubani P, Hasan AZ, Truelove SA, Winter AK, Carcelen AC, Lau B, Moss WJ, Wesolowski A.
Am J Epidemiol. 2024 Aug 27:kwae304.
doi: 10.1093/aje/kwae304. Online ahead of print.PMID: 39191642
-
Onward transmission of measles virus among vaccinated cases in a large community outbreak in Auckland, New Zealand, 2019.
Evans I, Jury S, Morrison A, Best E, King V, Reynolds E.
Vaccine. 2024 Oct 3;42(23):126257.
doi: 10.1016/j.vaccine.2024.126257. Epub 2024 Aug 27.PMID: 39191179
-
Socio-demographic factors affecting the first and second dose of measles vaccination status among under-five children: Perspectives from South Asian countries.
Mahazabin M, Tabassum N, Syfullah SMK, Majumder UK, Islam MA.
Prev Med Rep. 2024 Jul 31;45:102839.
doi: 10.1016/j.pmedr.2024.102839. eCollection 2024 Sep.PMID: 39188972
-
Onward Virus Transmission after Measles Secondary Vaccination Failure.
Tranter I, Smoll N, Lau CL, Williams DL, Neucom D, Barnekow D, Dyda A.
Emerg Infect Dis. 2024 Sep;30(9):1747-1754.
doi: 10.3201/eid3009.240150.PMID: 39173667
-
Congenital rubella syndrome, a case series.
Medu O, Mahajan P, Hennink M, Stang L, Anderson M, Tan B, Oyenubi A, Plamondon M, Salvadori MI, Franklin K, Primeau C, Hiebert J, Minion J, Diener T.
Can Commun Dis Rep. 2024 Jul 24;50(7-8):274-281.
doi: 10.14745/ccdr.v50i78a05. eCollection 2024 Jul-Aug.PMID: 39170592
-
Measles immunity status in Iranian infants and children and outbreak concerns: Time for reconsidering the vaccination schedule?
Pourakbari B, Ashraf Talesh S, Mahmoudi S, Sotoudeh M, Hosseinpour Sadeghi R, Mamishi S.
Vaccine. 2024 Oct 3;42(23):126243.
doi: 10.1016/j.vaccine.2024.126243. Epub 2024 Aug 20.PMID: 39168077
-
Individual and contextual factors associated with measles infection in Malaysia: a multilevel analysis.
Daud MRHM, Yaacob NA, Arifin WN, Sani JAM, Ibadullah WAHW.Osong
Public Health Res Perspect. 2024 Aug 21.
doi: 10.24171/j.phrp.2024.0156. Online ahead of print.PMID: 39164020
-
Predicting the Airborne Transmission of Measles: Impact of Indoor Carbon Dioxide (CO2) Levels and Mitigation Strategies.
Iwamura N, Tsutsumi K.
Cureus. 2024 Jul 19;16(7):e64882.
doi: 10.7759/cureus.64882. eCollection 2024 Jul.PMID: 39156354
-
An Alarming Emergence of Measles in Europe: Gaps and Future Directions.
Keske Ş, Özsürekci Y, Ergönül Ö.
Balkan Med J. 2024 Sep 6;41(5):321-323.
doi: 10.4274/balkanmedj.galenos.2024.060824. Epub 2024 Aug 16.PMID: 39150366
-
Quantifying the long-term effects of measles infection-a retrospective cohort study.
Dor E, Fluss R, Israel A, Huppert A.
Clin Microbiol Infect. 2024 Aug 12:S1198-743X(24)00393-8.
doi: 10.1016/j.cmi.2024.08.007. Online ahead of print.PMID: 39142629
-
Impact of the COVID-19 Pandemic on Measles Vaccination Coverage and Estimated Catch-up Efforts for Serbia.
Burgess C, Lisul B, Pawaskar M, Petigara T, Murtagh J, Kanazir M, Loncarevic G, Carias C.
Pediatr Infect Dis J. 2024 Oct 1;43(10):1011-1017.
doi: 10.1097/INF.0000000000004487. Epub 2024 Sep 16.PMID: 39105529
-
The Resurgence of Measles: A Rash From the Past.
Gooch MD.
Adv Emerg Nurs J. 2024 Jul-Sep 01;46(3):217-227.
doi: 10.1097/TME.0000000000000521. Epub 2024 Aug 1.PMID: 39094081
-
Measles virus: Continued outbreaks while striving for eradication.
Sanchez DJ.
Virulence. 2024 Dec;15(1):2386022.
doi: 10.1080/21505594.2024.2386022. Epub 2024 Aug 2.PMID: 39092662
-
A historical syndemic? The impact of synergistic epidemics of measles and scarlet fever on life expectancy in Victoria, Australia (1860s-1870s).
Battles HT, Roberts PM.
Am J Biol Anthropol. 2024 Aug 1:e25008.
doi: 10.1002/ajpa.25008. Online ahead of print.PMID: 39087439
-
Increase in measles cases in a City hospital, Istanbul, Turkey.
Karabey M, Karabulut N, Alaçam S, Gündüz A, Caymaz C, Altuntaş Aydin Ö.Cent
Eur J Public Health. 2024 Jun;32(2):125-131.
doi: 10.21101/cejph.a7981.PMID: 39069316
-
Rising measles cases in Europe-a threat to children.
Das M.
Lancet Infect Dis. 2024 Aug;24(8):e489.
doi: 10.1016/S1473-3099(24)00449-3.PMID: 39067473 No abstract available.
-
Challenges for Sustaining Measles Elimination: Post-Verification Large-Scale Import-Related Measles Outbreaks in Mongolia and Cambodia, Resulting in the Loss of Measles Elimination Status.
Hagan J, Dashpagma O, Vichit O, Chham S, Demberelsuren S, Grabovac V, Hossain S, Iijima M, Lee CW, Purevdagva A, Mariano K, Evans R, Zhang Y, Takashima Y.
Vaccines (Basel). 2024 Jul 22;12(7):821.
doi: 10.3390/vaccines12070821.PMID: 39066458
-
"Anees Has Measles": Storytelling and Singing to Enhance MMR Vaccination in Child Care Centers Amid Religious Hesitancy.
Thongseiratch T, Khantee P, Jaroenmark N, Nuttapasit N, Thonglua N.
Vaccines (Basel). 2024 Jul 22;12(7):819.
doi: 10.3390/vaccines12070819.PMID: 39066456
-
A Cross-Sectional Study of Measles-Specific Antibody Levels in Australian Blood Donors-Implications for Measles Post-Elimination Countries.
Williamson KM, Faddy H, Nicholson S, Stambos V, Hoad V, Butler M, Housen T, Merritt T, Durrheim DN.
Vaccines (Basel). 2024 Jul 22;12(7):818.
doi: 10.3390/vaccines12070818.PMID: 39066455
-
Serosurveillance for Measles and Rubella.
Brady AM, El-Badry E, Padron-Regalado E, Escudero González NA, Joo DL, Rota PA, Crooke SN.
Vaccines (Basel). 2024 Jul 22;12(7):816.
doi: 10.3390/vaccines12070816.PMID: 39066453
-
Vaccination Week in the Americas: An Ongoing Initiative to Strengthen and Sustain Measles and Rubella Elimination in the Region.
Ropero AM, Kurtis H, Vulanovic L, Bravo-Alcántara P, Vera Antelo M, Ghiselli M.
Vaccines (Basel). 2024 Jul 22;12(7):812.
doi: 10.3390/vaccines12070812.PMID: 39066450
-
Global Update on Measles Molecular Epidemiology.
Bankamp B, Kim G, Hart D, Beck A, Ben Mamou M, Penedos A, Zhang Y, Evans R, Rota PA.
Vaccines (Basel). 2024 Jul 22;12(7):810.
doi: 10.3390/vaccines12070810.PMID: 39066448
-
Persistence of Antibodies against Measles, Mumps, and Rubella after the Two-Dose MMR Vaccination: A 7-Year Follow-Up Study.
Sarawanangkoor N, Wanlapakorn N, Srimuan D, Thatsanathorn T, Thongmee T, Poovorawan Y.
Vaccines (Basel). 2024 Jul 5;12(7):744.
doi: 10.3390/vaccines12070744.PMID: 39066382
-
Conflict and fragmented public health emergency management system in Tigray region of Northern Ethiopia: A double burden to accommodate resilient and advanced public health emergency management. A commentary review for policy-makers and a call to action.
Ajemu KF, Hadgu T, Gebreegziabher G, Ayele B, Gebretnsae H, Desta AA, Kahsay H.
Health Res Policy Syst. 2024 Sep 3;22(1):121.
doi: 10.1186/s12961-024-01176-w.PMID: 39227920
-
Successful Elimination of Endemic Rubella in the WHO European Region. Is It Proper to Remove the Recommendation for Preconceptional Immunization?
Cavaliere AF, Parasiliti M, Franco R, Gallitelli V, Perelli F, Spanò A, Pallone B, Serafini MG, Signore F, Eleftheriou G, Scambia G, Lanzone A, Vidiri A.Int
J Environ Res Public Health. 2024 Jul 22;21(7):957.
doi: 10.3390/ijerph21070957.PMID: 39063533
-
Appropriateness of Immunoglobulin M Testing for Measles, Mumps, and Rubella.
Filardo TD, Masters NB, Leung J, Baca S, Egwuogu H, Guevara OR, Raykin J, Sugerman DE.
Am J Prev Med. 2024 Jul 23:S0749-3797(24)00255-1.
doi: 10.1016/j.amepre.2024.07.014. Online ahead of print.PMID: 39053655
-
The reemergence of measles and the urgent need for uninterrupted genetic surveillance and vaccination.
Branda F, Giovanetti M, Romano C, Ciccozzi A, Sanna D, Ciccozzi M, Scarpa F.
Clin Microbiol Infect. 2024 Oct;30(10):1215-1218.
doi: 10.1016/j.cmi.2024.06.023. Epub 2024 Jul 22.PMID: 39048053 No abstract available.
-
Global resurgence of measles in the vaccination era and influencing factors.
Bidari S, Yang W.
Int J Infect Dis. 2024 Oct;147:107189.
doi: 10.1016/j.ijid.2024.107189. Epub 2024 Jul 23.PMID: 39048035
-
Measles Outbreak in Socioeconomically Diverse Sections: A Review.
Lanke R, Chimurkar V.
Cureus. 2024 Jun 21;16(6):e62879.
doi: 10.7759/cureus.62879. eCollection 2024 Jun.PMID: 39044898
-
Characteristics of patients admitted to the intensive care unit during the 2019 measles epidemic in Samoa: A retrospective clinical case series.
Vaai-Bartley CS, Bennett E, Arasi F, Kaspar A.
Trop Doct. 2024 Jul 23:494755241266673.
doi: 10.1177/00494755241266673. Online ahead of print.PMID: 39043033
-
Measles Back to the Future: Chicago's Current Measles Outbreak Demands the Creation of Federally Managed Isolation Housing Reminiscent of the Origin Story of the Vaccines for Children Program.
Fricchione MJ, Nguyen DC, Nash CB, Davis ES.
J Public Health Manag Pract. 2024 Sep-Oct 01;30(5):647-648.
doi: 10.1097/PHH.0000000000001992. Epub 2024 Jul 22.PMID: 39041760 No abstract available.
-
The Epidemiological Characteristics and Spatiotemporal Clustering of Measles - China, 2005-2022.
Liu Q, Li J, Liu S, Tang L, Wang X, Huang A, Xu X, Xiu Y, Yang H, Wen N, Rodewald L, Wang F, Yin Z.China
CDC Wkly. 2024 Jul 5;6(27):665-669.
doi: 10.46234/ccdcw2024.123.PMID: 39027631
-
On mathematical modelling of measles disease via collocation approach.
Ahmed S, Jahan S, Shah K, Abdeljawad T.
AIMS Public Health. 2024 May 6;11(2):628-653.
doi: 10.3934/publichealth.2024032. eCollection 2024.PMID: 39027389
Routine Immunization Citations, Third Quarter 2024
-
An Interrupted Time Series Analysis of the Impact of the COVID-19 Pandemic on Routine Vaccination Uptake in Kenya.
Ngigi M, Moride Y, Castilloux AM, Clemens SAC.
Vaccines (Basel). 2024 Jul 23;12(8):826.
doi: 10.3390/vaccines12080826.PMID: 39203951
-
Vaccine practices, literacy, and hesitancy among parents in the United Arab Emirates.
0Barqawi HJ, Samara KA, Kannas SM, Habbal O, AlSarraf NA, Dreezi MA, Abu-Gharbieh E.
PLoS One. 2024 Aug 27;19(8):e0307020.
doi: 10.1371/journal.pone.0307020. eCollection 2024.PMID: 39190761
-
Timeliness of Childhood Vaccinations Following Strengthening of the Second Year of Life (2YL) Immunization Platform and Introduction of Catch-Up Vaccination Policy in Ghana.
Muhoza P, Shah MP, Amponsa-Achiano K, Gao H, Quaye P, Opare W, Okae C, Aboyinga PN, Opare JKL, Ehlman DC, Wardle MT, Wallace AS.
Vaccines (Basel). 2024 Jun 27;12(7):716.
doi: 10.3390/vaccines12070716.PMID: 39066354
-
The Effect of Economic Growth on the Utilisation of Childhood Immunisation: New Evidence From 50 African Countries.
Immurana M, Abdul Rahman AM.
Health Serv Insights. 2024 Jul 24;17:11786329241261990.
doi: 10.1177/11786329241261990. eCollection 2024.PMID: 39049962
-
Navigating Pakistan's immunization landscape: Progress and pitfalls.
Ashraf MF, Daim SUR, Fayyaz H, Ashraf MA, Ashraf M.
IJID Reg. 2024 Jun 3;12:100382.
doi: 10.1016/j.ijregi.2024.100382. eCollection 2024 Sep.PMID: 39036066
-
Evaluating the impact of COVID-19 on routine childhood immunizations coverage in Zambia.
Mwangilwa K, Chileshe C, Simwanza J, Chipoya M, Simwaba D, Kapata N, Mazaba ML, Mbewe N, Muzala K, Sinyange N, Fwemba I, Chilengi R.
PLOS Glob Public Health. 2024 Jul 30;4(7):e0003407.
doi: 10.1371/journal.pgph.0003407. eCollection 2024.PMID: 39078841
-
Human health implications of emerging diseases and the current situation in India's vaccine industry.
Behera JK, Mishra P, Jena AK, Behera B, Bhattacharya M.
Sci One Health. 2023 Oct 29;2:100046.
doi: 10.1016/j.soh.2023.100046. eCollection 2023.PMID: 39077045
-
Factors contributing to immunization coverage among children less than 5 years in Nadowli-Kaleo District of Upper West Region, Ghana.
Kuuyi A, Kogi R.
PLOS Glob Public Health. 2024 Aug 1;4(8):e0002881.
doi: 10.1371/journal.pgph.0002881. eCollection 2024.PMID: 39088462
-
Strengthening life-course immunisation in migrant populations: access, equity, and inclusion.Knights F, Carter J, Deal A, Crawshaw A, Bouaddi O, Sanchez-Clemente N, Seedat F, Vanderslott S, Eagan R, Holt DE, Ciftci Y, Orcutt M, Seale H, Severoni S, Hargreaves S. Lancet Reg Health Eur. 2024 May 28;41:100806. doi: 10.1016/j.lanepe.2023.100806. eCollection 2024 Jun.PMID: 39119098 Free PMC article.
Knights F, Carter J, Deal A, Crawshaw A, Bouaddi O, Sanchez-Clemente N, Seedat F, Vanderslott S, Eagan R, Holt DE, Ciftci Y, Orcutt M, Seale H, Severoni S, Hargreaves S.
Lancet Reg Health Eur. 2024 May 28;41:100806.
doi: 10.1016/j.lanepe.2023.100806. eCollection 2024 Jun.PMID: 39119098
-
Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program - United States, 1994-2023.
Zhou F, Jatlaoui TC, Leidner AJ, Carter RJ, Dong X, Santoli JM, Stokley S, Daskalakis DC, Peacock G.
MMWR Morb Mortal Wkly Rep. 2024 Aug 8;73(31):682-685.
doi: 10.15585/mmwr.mm7331a2.PMID: 39116024
-
Strengthening life-course immunisation in migrant populations: access, equity, and inclusion.
Knights F, Carter J, Deal A, Crawshaw A, Bouaddi O, Sanchez-Clemente N, Seedat F, Vanderslott S, Eagan R, Holt DE, Ciftci Y, Orcutt M, Seale H, Severoni S, Hargreaves S.
Lancet Reg Health Eur. 2024 May 28;41:100806.
doi: 10.1016/j.lanepe.2023.100806. eCollection 2024 Jun.PMID: 39119098
-
Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program - United States, 1994-2023.
Zhou F, Jatlaoui TC, Leidner AJ, Carter RJ, Dong X, Santoli JM, Stokley S, Daskalakis DC, Peacock G.
MMWR Morb Mortal Wkly Rep. 2024 Aug 8;73(31):682-685.
doi: 10.15585/mmwr.mm7331a2.PMID: 39116024
-
Strengthening life-course immunisation in migrant populations: access, equity, and inclusion.
Knights F, Carter J, Deal A, Crawshaw A, Bouaddi O, Sanchez-Clemente N, Seedat F, Vanderslott S, Eagan R, Holt DE, Ciftci Y, Orcutt M, Seale H, Severoni S, Hargreaves S.
Lancet Reg Health Eur. 2024 May 28;41:100806.
doi: 10.1016/j.lanepe.2023.100806. eCollection 2024 Jun.PMID: 39119098
-
Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program - United States, 1994-2023.
Zhou F, Jatlaoui TC, Leidner AJ, Carter RJ, Dong X, Santoli JM, Stokley S, Daskalakis DC, Peacock G.
MMWR Morb Mortal Wkly Rep. 2024 Aug 8;73(31):682-685.
doi: 10.15585/mmwr.mm7331a2.PMID: 39116024
-
Vital Signs: Trends and Disparities in Childhood Vaccination Coverage by Vaccines for Children Program Eligibility - National Immunization Survey-Child, United States, 2012-2022.
Valier MR, Yankey D, Elam-Evans LD, Chen M, Hill HA, Mu Y, Pingali C, Gomez JA, Arthur BC, Surtees T, Graitcer SB, Dowling NF, Stokley S, Peacock G, Singleton JA.
MMWR Morb Mortal Wkly Rep. 2024 Aug 22;73(33):722-730.
doi: 10.15585/mmwr.mm7333e1.PMID: 39173180
-
Discovering vaccines: the trial tale.
Vinusha V, Girish C.Naunyn Schmiedebergs
Arch Pharmacol. 2024 Aug 23.
doi: 10.1007/s00210-024-03368-1. Online ahead of print.PMID: 39177789 Review.
-
Possible counter-intuitive impact of local vaccine mandates for vaccine-preventable infectious diseases.
Donà M, Trapman P.
Math Biosci Eng. 2024 Jul 8;21(7):6521-6538.
doi: 10.3934/mbe.2024284.PMID: 39176406
-
SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study.
Gonella LA, Moretti F, Capuano A, De Sarro C, Ferrara L, Geninatti E, Guarnieri G, Hysolakoj X, Lalli M, Leoni O, Mangano AMP, Marani Toro P, Mecchia V, Merlano MC, Palleria C, Potenza AM, Rossi P, Rossi M, Sanità F, Sapigni E, Scavone C, Sommaro C, Tuccori M, Zanoni G, Moretti U, VigiVax Working Group.
Vaccines (Basel). 2024 Sep 20;12(9):1076.
doi: 10.3390/vaccines12091076.PMID: 39340106
-
Increasing immunization coverage, Solomon Islands, 2022.
Angessa R, Siliota R, Anga J, Kofela T, Tanevska S, Bainvalu N, McNeil P, Sobel HL.
Bull World Health Organ. 2024 Oct 1;102(10):736-741.
doi: 10.2471/BLT.24.291084. Epub 2024 Sep 2.PMID: 39318888
-
Vaccine Completion and Timeliness Among Children in the Military Health System: 2010-2019.
Romano CJ, Burrell M, Bukowinski AT, Hall C, Gumbs GR, Conlin AMS, Ramchandar N.
Pediatrics. 2024 Oct 1;154(4):e2023064965.
doi: 10.1542/peds.2023-064965.PMID: 39295511
-
Minimizing Vaccine Wastage in Nigeria: A National Assessment of Vaccine Wastage Rates and Potential Determinants.
Lambo K, Prescott M, Wiwa O, Adebowale J, Daradara K.
Vaccines (Basel). 2024 Aug 8;12(8):900.
doi: 10.3390/vaccines12080900.PMID: 39204026
Partnership Alliance
The mark 'CDC' is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or enterprise. CDC's logo and work with the Partnership is not connected to any fundraising aspect of the organization.
Follow Us
Prelude Version 2.3.2